Pharmaron Beijing Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

4,398.05

3,982.54

3,606.11

3,313.18

3,740.15

3,496.01

3,166.98

Other Operating Income

0.00

Total Operating income

4,398.05

3,982.54

3,606.11

3,313.18

3,740.15

3,496.01

3,166.98

Raw Material Cost

2,877.78

2,680.03

2,444.68

2,196.33

2,494.96

2,353.55

2,158.40

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

56.10

51.89

54.27

46.91

54.39

60.03

73.07

Selling and Distribution Expenses

578.21

532.53

483.68

520.90

443.90

449.40

467.44

Other Expenses

13.30

8.91

7.51

8.38

8.33

6.49

4.07

Total Expenditure (Excl Depreciation)

3,645.04

3,353.59

3,057.73

2,847.90

3,076.60

2,927.88

2,739.56

Operating Profit (PBDIT) excl Other Income

753

629

548.4000000000001

465.3

663.6

568.1

427.40000000000003

Other Income

94.01

21.50

6.39

7.92

71.61

2.02

732.42

Operating Profit (PBDIT)

1,151.46

944.91

844.62

460.02

899.69

826.74

1,427.73

Interest

56.10

51.89

54.27

46.91

54.39

60.03

73.07

Exceptional Items

-2.87

54.52

33.71

0.00

25.59

-21.30

-1.54

Gross Profit (PBDT)

1,520.27

1,302.51

1,161.43

1,116.85

1,245.19

1,142.47

1,008.59

Depreciation

362.09

360.70

328.78

0.00

288.19

289.98

299.46

Profit Before Tax

730.40

586.84

495.28

413.11

582.70

455.43

1,053.66

Tax

103.62

112.48

82.21

89.74

134.57

118.35

98.46

Provisions and contingencies

0.00

Profit After Tax

573.67

480.26

427.08

326.71

401.81

335.58

953.04

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

573.67

480.26

427.08

326.71

401.81

335.58

953.04

Share in Profit of Associates

0.00

Minority Interest

-36.93

-28.71

-24.65

-27.71

-28.77

-24.09

-17.08

Other related items

0.00

Consolidated Net Profit

536.74

451.55

402.43

299.00

373.04

311.49

935.96

Equity Capital

0.00

Face Value

1.11

1.09

1.1

1.07

1.06

1.11

1.07

Reserves

16,778.67

15,971.87

15,628.74

15,065.75

14,493.86

14,820.89

13,982.37

Earnings per share (EPS)

0.32

0.27

0.24

0.19

0.23

0.19

0.54

Diluted Earnings per share

0.32

0.27

0.24

0.19

0.23

0.19

0.54

Operating Profit Margin (Excl OI)

15.81%

14.13%

13.65%

14.44%

15.3%

12.5%

Gross Profit Margin

24.84%

23.79%

22.85%

12.47%

23.29%

21.32%

42.73%

PAT Margin

13.04%

12.06%

11.84%

9.86%

10.74%

9.6%

30.09%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is 10.44% vs 10.44% in Sep 2025

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 18.84% vs 12.23% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 14.51% vs 10.16% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is 8.09% vs -4.42% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Pharmaron Beijing Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(HKD)

Change(%)

Net Sales

4,398.05

2,257.86

2,140.19

94.79%

Other Operating Income

0.00

Total Operating income

4,398.05

2,257.86

2,140.19

94.79%

Raw Material Cost

2,877.78

7.92

2,869.86

36,235.61%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

181.06

-181.06

-100.00%

Power Cost

0.00

Manufacturing Expenses

56.10

1,030.95

-974.85

-94.56%

Selling and Distribution Expenses

578.21

290.24

287.97

99.22%

Other Expenses

13.30

9.68

3.62

37.40%

Total Expenditure (Excl Depreciation)

3,645.04

1,606.96

2,038.08

126.83%

Operating Profit (PBDIT) excl Other Income

753.01

650.89

102.12

15.69%

Other Income

94.01

-12.05

106.06

880.17%

Operating Profit (PBDIT)

1,151.46

1,741.29

-589.83

-33.87%

Interest

56.10

1,030.95

-974.85

-94.56%

Exceptional Items

-2.87

-24.25

21.38

88.16%

Gross Profit (PBDT)

1,520.27

2,178.43

-658.16

-30.21%

Depreciation

362.09

71.51

290.58

406.35%

Profit Before Tax

730.40

614.59

115.81

18.84%

Tax

103.62

158.17

-54.55

-34.49%

Provisions and contingencies

0.00

Profit After Tax

573.67

429.70

143.97

33.50%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

573.67

429.70

143.97

33.50%

Share in Profit of Associates

0.00

Minority Interest

-36.93

16.89

-53.82

-318.65%

Other related items

0.00

Consolidated Net Profit

536.74

446.59

90.15

20.19%

Equity Capital

0.00

Face Value

1.11

0.00

Reserves

16,778.67

15,741.92

1,036.75

6.59%

Earnings per share (EPS)

0.32

0.05

0.27

540.00%

Diluted Earnings per share

0.32

0.05

0.27

540.00%

Operating Profit Margin (Excl OI)

15.81%

28.83%

0.00

-13.02%

Gross Profit Margin

24.84%

30.39%

0.00

-5.55%

PAT Margin

13.04%

19.03%

0.00

-5.99%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 439.81 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 10.44% vs 10.44% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 17.59% vs 16.21% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 53.67 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 18.84% vs 12.23% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 43.89% vs -22.84% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 105.74 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 14.51% vs 10.16% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 27.69% vs 15.66% in Dec 2024

Quarterly - Interest

Interest 5.61 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 8.09% vs -4.42% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 3.12% vs 4.62% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 15.81%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024